Analystreport

Castle Biosciences, Inc. (NASDAQ: CSTL) had its price target raised by analysts at KeyCorp from $25.00 to $28.00. They now have an "overweight" rating on the stock.

Castle Biosciences, Inc. - Common stock  (CSTL) 
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm Check Earnings Report